SEPTInvestingStart Free

QNCX SCHEDULE 13G: SEC filing

A Schedule 13G was

Filed with the SEC on · accession 0001193125-26-421651

QNCX filed a SCHEDULE 13G (schedule 13g) with the SEC on Oct 14, 2026. A Schedule 13G was filed indicating a passive ownership position in QNCX (IRulya Therapeutics Inc.).

Summary of the filing

A Schedule 13G was filed indicating a passive ownership position in QNCX (IRulya Therapeutics Inc.). The filing text provided is only the EDGAR directory listing and does not contain the substantive ownership details.

For details, click here →

Key details

IssuerIRulya Therapeutics Inc.

✦ Ask GOAX AI about this filing — what it means for QNCX, what changed since its last filings and what to watch next.

Try it free for 7 days

🔔 Want to stay updated on new SEC filings for QNCX?

Click here

Frequently asked questions

What did QNCX file with the SEC on Oct 14, 2026?

QNCX filed a SCHEDULE 13G (SEC filing). A Schedule 13G was filed indicating a passive ownership position in QNCX (IRulya Therapeutics Inc.). The filing text provided is only the EDGAR directory listing and does not contain the substantive ownership details.

How do I read a SCHEDULE 13G?

A report the company filed with the SEC (the US market regulator). Start with the summary, then the key amounts and names. Compare it with the company’s earlier filings.

Why are SEC filings important?

Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A SCHEDULE 13G (schedule 13g): A report the company filed with the SEC (the US market regulator).

Other QNCX SEC filings

Get alerts when QNCX files with the SEC, plus live charts, key levels and news for 13,000+ stocks.

Try SEPT free for 7 days
QNCX overviewQNCX analysisQNCX newsLatest SEC filings